-
#25. Sinopharm Group
$9.76 billion
-
#24. Jazz Pharmaceuticals
$9.95 billion
-
#23. Dr. Reddy Laboratories
$10.45 billion
-
#22. Merck KGaA
$12.19 billion (€10.88 billion)
-
#21. Endo International
$15.20 billion
-
#20. UCB
$15.54 billion (€13.89 billion)
-
#19. Actelion2
$15.67 billion (CHF 15.24 billion)
-
#18. BioMarin Pharmaceutical
$20.38 billion
-
#17. Incyte
$20.91 billion
-
#16. Mylan
$23.62 billion
-
#15. Perrigo
$26.15 billion
-
#14. CSL
$29.65 billion (A$42.19 billion)
-
#13. Sun Pharmaceutical Industries
$30.60 billion (INR 2,032.48 billion)
-
#12. Vertex Pharmaceuticals
$31.07 billion
-
#11. Alexion Pharmaceuticals
$39.89 billion
-
#10. Shire3
$45.90 billion (£29.009 billion)
-
#9. Regeneron Pharmaceuticals
$51.84 billion
-
#8. Teva Pharmaceutical Industries
$53.25 billion
-
#7. Biogen
$71.08 billion
-
#6. Valeant Pharmaceuticals International
$78.68 billion
-
#5. Celgene
$92.80 billion
-
#4. Amgen
$111.48 billion
-
#3. Allergan
$115.63 billion
-
#2. Novo Nordisk
$143.92 billion
-
#1. Gilead Sciences
$149.78 billion
Source: http://www.genengnews.com/insight-and-intelligence/top-25-biotech-companies-of-2015/77900519/
0 Comments